Global Neurovascular Thrombectomy Devices Market Size 2015-2030, by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape and Procedures – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Neurovascular Thrombectomy Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Neurovascular Thrombectomy Devices market for the year 2020 and beyond. Neurovascular thrombectomy devices … [Read more…]

Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022

Extension allows for satisfaction of the HSR Condition as outlined in the Merger Agreement Epizyme stockholders are encouraged to tender their shares to the offer today PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the … [Read more…]

Acadia Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for NUPLAZID® (pimavanserin) for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The CRL indicated that the … [Read more…]

CORRECTING and REPLACING flipMD Launches New Industry-Disrupting Recruiting Platform, flipMD Hire

 An innovative and cost-effective alternative to traditional staffing firms, the flipMD Hire platform allows healthcare companies to now recruit for full-time and temporary physician positions, in addition to consulting opportunities PHILADELPHIA–(BUSINESS WIRE)–Please replace the release dated August 3, 2022 with the following corrected version due to multiple revisions. The updated release reads: FLIPMD LAUNCHES NEW … [Read more…]

AHF Hails President Biden on Monkeypox Emergency Declaration

AHF thanks U.S. President Joe Biden for proclaiming a national state of emergency on monkeypox earlier today; urges federal government to immediately allocate money, staff and resources nationally LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) commended President Joseph Biden for proclaiming a national state of emergency on monkeypox earlier today. The move comes as more than … [Read more…]

McKesson Medical-Surgical Supports National Health Center Week 2022

RICHMOND, Va.–(BUSINESS WIRE)–McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Center (NACHC) National Health Center Week 2022 (NHCW) on Aug. 7-13. The theme of NHCW 2022 is “Community Health Centers: The Chemistry for Strong Communities.” As a strong supporter of the nation’s … [Read more…]

Merrimack Reports Second Quarter 2022 Financial Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its second quarter 2022 financial results for the period ended June 30, 2022. “We are pleased to report continued reductions in operating expenses as we remain focused on conserving cash to ensure that we have sufficient financial resources to capture future potential … [Read more…]

SQZ Biotechnologies Reports Second Quarter 2022 Financial Results and Recent Portfolio Updates

Granted FDA Fast Track Designation for APC Clinical Candidate Published Comprehensive Preclinical Research on SQZ® TAC Platform in Frontiers in Immunology Presented First SQZ® Point-of-Care (POC) Manufacturing System Performance Data; Initial Clinical Use Planned for SQZ® TAC Celiac Disease Program with IND Submission Expected in First Half 2023 Strengthened Leadership with Experienced CMO and CFO … [Read more…]

Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as … [Read more…]

Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference

EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the Canaccord Genuity … [Read more…]